Drug Trial Radar · NCT01114217
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
Last checked: Nov 20, 2026Latest source record: Apr 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
634
Actual
Start
Jul 27, 2010
Primary completion
Sep 24, 2012
Study completion Apr 23, 2013
Sponsor
- Lead sponsor
- AMAG Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 3, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).
Conditions
- Iron Deficiency Anemia
Interventions
FerumoxytolDrug
IV Ferumoxytol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change In Hemoglobin From TP Baseline To TP Week 5 Following The First Course Of FerumoxytolTime frame: TP Baseline (Day 1), TP Week 5
Locations
140 sites in 6 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Birmingham, Alabama
Clinical Trial Site
Mobile, Alabama
Clinical Trial Site
Montgomery, Alabama
Clinical Trial Site
Montgomery, Alabama
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Tucson, Arizona
Clinical Trial Site
Tucson, Arizona
Clinical Trial Site
Anaheim, California
Clinical Trial Site
Bakersfield, California
Clinical Trial Site
Buena Park, California
Clinical Trial Site
Colton, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Mission Hills, California
Clinical Trial Site
Orange, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
Pueblo, Colorado
Clinical Trial Site
Bristol, Connecticut
Clinical Trial Site
Groton, Connecticut
Clinical Trial Site
Boynton Beach, Florida
Clinical Trial Site
Boynton Beach, Florida
Clinical Trial Site
Clearwater, Florida
Clinical Trial Site
Clearwater, Florida
Clinical Trial Site
Hialeah, Florida
Clinical Trial Site
Holiday, Florida
Clinical Trial Site
Inverness, Florida
Clinical Trial Site
Margate, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami Lakes, Florida
Clinical Trial Site
Naples, Florida
Clinical Trial Site
Vero Beach, Florida
Clinical Trial Site
West Palm Beach, Florida
Showing 40 of 140 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.